Year-over-year earnings per share growth for the last twelve months: Accelerate Diagnostics (AXDX)
The slow integration of Pheno systems into clinics is leading to losses and capital deficits for Accelerate Diagnostics (AXDX). This chart from GURU.Markets illustrating quarterly EPS growth demonstrates a sideways trend, where 0.00 represents the latest metric reading. Revenues are based on the sale of equipment and reagents, while the sale of resistance test cards generates recurring revenue, enhancing FCF potential.
Analytical breakdowns and data insights for company Accelerate Diagnostics Inc (AXDX)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Accelerate Diagnostics|AXDX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Accelerate Diagnostics|AXDX - Company Cumulative Debt|Debt to Book Capitalization Ratio Accelerate Diagnostics, Inc|AXDX - Company Long-Term Debt|Company Short-Term Debts Accelerate Diagnostics|Quick Liquidity acceleratediagnostics.com
- earnings and valuation multiples indicators:
AXDX - Final Profit|Projected Future Earnings Accelerate Diagnostics|AXDX - P/E Multiple|Projected Price to Earnings Accelerate Diagnostics, Inc|AXDX - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Accelerate Diagnostics, Inc|AXDX - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Accelerate Diagnostics|AXDX - Earnings per share for the trailing year|Quarterly EPS earnings growth acceleratediagnostics.com|AXDX - Earnings per share growth this year|Earnings growth forecast for next year Accelerate Diagnostics
Comprehensive company analysis:Accelerate Diagnostics
This indicator assesses the quarterly dynamics of earnings per share, reflecting the efficiency of value generation and the rate of change in asset yield. By analyzing the quarter-over-quarter growth in earnings per share, an investor can see the critical dependence of Accelerate Diagnostics (AXDX) on the adoption rates of Pheno systems, where a negative trajectory of the curve confirms an operational deficit and the risk of liquidity depletion for the company.
Direct competitors
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth RVTY|Quarterly EPS earnings growth bio-rad.com (BIO)|Quarterly EPS earnings growth NNNN (Anbio)|SHC - Year-over-year net earnings per share growth for the last 12 months|QuidelOrtho Corp - Quarterly EPS earnings growth|OPKO Health Corp. (OPK) - Year-over-year net earnings per share growth for the last 12 months|CDNA: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months maravai.com (MRVI)|Year-over-year earnings per share growth for the last twelve months Fulgent Genetics|Year-over-year earnings per share growth for the last twelve months LAB|Quarterly EPS earnings growth CTKB|OSUR - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Exagen XGN|Year-over-year earnings per one share growth for the last 12 months MDXH|Lucid Diagnostics - Quarterly EPS earnings growth|PRE - Quarterly EPS earnings growth|IMDX (imdxinc.com) - Year-over-year net earnings per share growth for the last 12 months|TRIB: Year-over-year earnings per share growth rate for the last twelve months|PRPH (ProPhase Labs, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ainos.com AIMD|Year-over-year net earnings per share growth for the last 12 months CODX (Co-Diagnostics)|HSCS (Heart Test Laboratories, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth BMRA (Biomerica, Inc)|CDIO: Year-over-year earnings per share growth for the last 12 months|Onconetix, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months viraxbiolabs.com VRAX|BJDX: Quarterly EPS earnings growth|Aspira Women's Health, Inc. (AWH) - Quarterly EPS earnings growth|CNTG (CENTOGENE) - Quarterly EPS earnings growth|ENZ - Net earnings per share growth for the trailing year|Year-over-year earnings per share growth for the last twelve months Fresh2 Group Limited (FRES)|gtglabs.com - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months 23andMe ME|Psychemedics Corp. (PMD) - Earnings per share growth in annualized terms for the last twelve months
